Skip to main content
. Author manuscript; available in PMC: 2016 May 11.
Published in final edited form as: J Health Econ. 2012 Dec 17;32(6):1313–1324. doi: 10.1016/j.jhealeco.2012.11.006

Table 8.

Monthly WTP estimates obtained from MNL models with combined hypothetical and real choice data (using the delta method)

(3) (4)
Insurance 25.96***
(2.40)		 21.29***
(3.58)
No deductible 18.40***
(2.25)		 24.03***
(3.14)
Gap coverage (generics) 2.70
(3.48)		 1.53
(3.03)
Gap coverage (brand-name drugs) 13.83***
(1.83)		 17.97***
(4.03)
Drug tiers −25.15***
(3.06)		 −25.74***
(3.40)
Top 100 drugs uncovered −2.49***
(0.42)		 −1.84***
(0.39)
Top 100 with authorization −1.90***
(0.24)		 −1.52***
(0.24)
***

p<0.01,

**

p<0.05,

*

p<0.1